On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C.
Po-Sung ChuNobuhiro NakamotoNobuhito TanikiKeisuke OjiroTakeru AmiyaYuko MakitaHiroko MurataAkihiro YamaguchiShunsuke ShibaRei MiyakeTadashi KatayamaAya UgamuraAkihiko IkuraKarin TakedaHirotoshi EbinumaHidetsugu SaitoTakanori KanaiPublished in: PloS one (2017)
On-treatment decrease of NKG2D may be a useful predictor of early emerging HCC in patients treated with IFN-free DAAs.